Παραπομπή σε μορφή APA (7η εκδ.)

Zheng, H., Qin, X., Zheng, Y., Yang, X., Tan, J., Cai, W., . . . Liao, H. (2024). Addition of bevacizumab to EGFR tyrosine kinase inhibitors in advanced NSCLC: An updated systematic review and meta-analysis. Frontiers Media S.A.

Παραπομπή σε μορφή Chicago (17η εκδ.)

Zheng, Haosheng, Xianyu Qin, Yuzhen Zheng, Xingping Yang, Jian Tan, Weijie Cai, Shiyun He, και Hongying Liao. Addition of Bevacizumab to EGFR Tyrosine Kinase Inhibitors in Advanced NSCLC: An Updated Systematic Review and Meta-analysis. Frontiers Media S.A, 2024.

Παραπομπή σε μορφή MLA (9th εκδ.)

Zheng, Haosheng, et al. Addition of Bevacizumab to EGFR Tyrosine Kinase Inhibitors in Advanced NSCLC: An Updated Systematic Review and Meta-analysis. Frontiers Media S.A, 2024.